(NaturalNews) The FDA approved Zevaskyn, the first cell-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB), a rare and painful genetic dis…
FDA approves first cell-based gene therapy for rare, devastating skin disorder â but it comes with a huge price tag
Estimated read time
1 min read
You May Also Like
More From Author
GTA VI proves discipline can make you a better sinner
November 22, 2026
Islam to overtake Christianity by 2035 as the West loses its faith
November 22, 2026
